Sequana Medical NV Investor Presentation 2021

Sequana Medical NV presents its therapeutic solutions for managing fluid overload associated with liver disease, malignant ascites, and heart failure. The presentation highlights the alfapump® system, which is under clinical investigation in the United States and Canada, and discusses DSR therapy in development. The company is developing innovative medical devices to address refractory and recurrent ascites management.